1.8
L'interazione farmaco-recettore descrive il legame dei recettori da parte dei farmaci, ma non tutte le interazioni farmaco-recettore portano all'attiv…
Un farmaco attiva il suo recettore inducendo cambiamenti conformazionali o reclutando molecole effettrici per generare una risposta cellulare. Tuttavia, non tutti i farmaci attivano il loro bersaglio o recettori dopo il legame.
Il legame del farmaco dipende dall'affinità del farmaco per il recettore. Anche a basse concentrazioni, i farmaci ad alta affinità competono con i ligandi endogeni per la massima occupazione del recettore.
L'efficacia di un farmaco determina la sua capacità di suscitare una risposta cellulare. I farmaci sono classificati come agonisti, agonisti parziali o antagonisti in base alla loro affinità ed efficacia.
Un agonista attiva il recettore per suscitare una risposta massima. Gli agonisti possono legarsi a un sito di legame del ligando endogeno o a un sito allosterico separato per aumentare l'attività di un recettore. Anche senza l'occupazione totale dei recettori, l'efficacia di un agonista rimane quasi del 100%.
Un agonista parziale ha un'efficacia intermedia e può produrre solo una risposta submassimale anche con un'occupazione del recettore del 100%.
Infine, un antagonista compete con il ligando endogeno per legare e inattivare il recettore. Quindi, l'antagonista ha un'efficacia trascurabile e non produce una risposta.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between drug affinity and drug efficacy?
Drug affinity is the ability of a drug to bind to its receptor, determining how readily it occupies receptor sites even at low concentrations. Efficacy is the drug's ability to activate the receptor and elicit a cellular response. High-affinity drugs compete effectively with endogenous ligands for receptor occupancy, while efficacy determines whether that binding produces a maximal, submaximal, or negligible response.
Q2: How do agonists activate receptors to produce a cellular response?
Agonists activate receptors by inducing conformational changes or recruiting effector molecules that generate a cellular response. They can bind to the endogenous ligand binding site or a separate allosteric site to increase receptor activity. Agonists have high affinity and nearly 100% efficacy, producing maximal responses even without total receptor occupancy.
Q3: Why do partial agonists produce submaximal responses despite full receptor occupancy?
Partial agonists have intermediate efficacy, meaning they cannot fully activate receptors even when bound to all available receptor sites. Unlike agonists with nearly 100% efficacy, partial agonists are intrinsically limited in their ability to generate a cellular response. This reduced efficacy results in submaximal tissue responses regardless of complete receptor occupancy.
Q4: What mechanism allows antagonists to block drug responses?
Antagonists compete with endogenous ligands and agonists for receptor binding sites, stabilizing the receptor in an inactive state. They have negligible efficacy and do not produce a response themselves. By occupying receptors, antagonists prevent agonists from binding and activating the receptor, effectively blocking the cellular response.
Q5: How do allosteric antagonists differ from pharmacologic antagonists?
Pharmacologic antagonists compete directly with other molecules for the same receptor binding site and stabilize the receptor in an inactive state. Allosteric antagonists bind to separate sites on the receptor and change the affinity and efficacy of agonists without competing for the primary binding site. Both reduce receptor activation but through distinct mechanisms.
Q6: Why is understanding drug-receptor binding essential for predicting drug effects?
Drug-receptor interactions determine whether a drug activates or inactivates its target, directly influencing tissue response. The drug's affinity, efficacy, and binding mechanism—whether at the agonist site or allosteric site—collectively determine its pharmacological effect. Understanding these interactions is critical for predicting how factors affecting drug response will influence therapeutic outcomes.
Q7: What determines whether a drug will be classified as an agonist, partial agonist, or antagonist?
Drug classification depends on two parameters: affinity and efficacy. Agonists have high affinity and high efficacy, producing maximal responses. Partial agonists have high affinity but intermediate efficacy, producing submaximal responses. Antagonists have variable affinity but negligible efficacy, producing no response. These properties determine the drug's functional effect on tissue.